Bamifylline: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Bamifylline''' is a [[drug]] of the [[xanthine]] [[chemical class]] which acts as a [[functional_selectivity|selective]] [[Adenosine receptor | '''Bamifylline''' is a [[drug]] of the [[xanthine]] [[chemical class]] which acts as a [[functional_selectivity|selective]] [[Adenosine receptor|Adenosine receptor A1]] | ||
== See also == | == See also == | ||
* [[Theophylline]] | * [[Theophylline]] | ||
Revision as of 20:03, 6 April 2015
|
WikiDoc Resources for Bamifylline |
|
Articles |
|---|
|
Most recent articles on Bamifylline Most cited articles on Bamifylline |
|
Media |
|
Powerpoint slides on Bamifylline |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Bamifylline at Clinical Trials.gov Clinical Trials on Bamifylline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Bamifylline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Bamifylline Discussion groups on Bamifylline Patient Handouts on Bamifylline Directions to Hospitals Treating Bamifylline Risk calculators and risk factors for Bamifylline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Bamifylline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bamifylline is a drug of the xanthine chemical class which acts as a selective Adenosine receptor A1